It suggests that upregulating NeuroD1 expression in pancreatic cancer cells via effective targeted drugs holds promise for inhibiting pancreatic cancer progression and offers new hope for pancreatic cancer treatment. Here, NEUROD1 is linked to pancreatic neoplasm.